For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control and weight reductions, according to research published in the the Annals of Internal Medicine.
Dapagliflozin aids glycemic control in type 2 diabetes
Posted in Type II Medical Research